Detalhe da pesquisa
1.
Comparative genomic analysis of PIK3R1-mutated and wild-type breast cancers.
Breast Cancer Res Treat
; 204(2): 407-414, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38153569
2.
Baseline characteristics and first-line treatment patterns in patients with HER2-positive metastatic breast cancer in the SystHERs registry.
Breast Cancer Res Treat
; 188(1): 179-190, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33641083
3.
De Novo Versus Recurrent HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from the SystHERs Registry.
Oncologist
; 25(2): e214-e222, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32043771
4.
Somatic loss of PIK3R1 may sensitize breast cancer to inhibitors of the MAPK pathway.
Breast Cancer Res Treat
; 177(2): 325-333, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31209687
5.
Somatic variants of potential clinical significance in the tumors of BRCA phenocopies.
Hered Cancer Clin Pract
; 17: 21, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31346352
6.
Hereditary diffuse gastric cancer and lynch syndromes in a BRCA1/2 negative breast cancer patient.
Breast Cancer Res Treat
; 166(1): 315-319, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28702897
7.
Mutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirin.
Breast Cancer Res Treat
; 156(1): 33-43, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26915040
8.
Trastuzumab-induced cardiac toxicity: Is serial assessment of left ventricular ejection fraction during treatment necessary?
Breast J
; 26(5): 1085-1086, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31674100
9.
Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study.
Cardiooncology
; 10(1): 3, 2024 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38225669
10.
Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43.
Breast Cancer Res Treat
; 142(2): 415-21, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24202240
11.
Impact of the 2018 ACR Supplemental Screening Recommendations on MRI Eligibility in Breast Cancer Survivors.
J Am Coll Radiol
; 20(1): 71-78, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36516954
12.
Comparison of gut microbiome composition in colonic biopsies, endoscopically-collected and at-home-collected stool samples.
Front Microbiol
; 14: 1148097, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37323911
13.
Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease.
J Clin Oncol
; 41(8): 1501-1510, 2023 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36881998
14.
Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer.
J Clin Oncol
; 41(9): 1638-1645, 2023 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36921335
15.
Adjuvant endocrine therapy for breast cancer.
Oncology (Williston Park)
; 26(6): 541-7, 550, 552 passim, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22870539
16.
The Phase II MutHER Study of Neratinib Alone and in Combination with Fulvestrant in HER2-Mutated, Non-amplified Metastatic Breast Cancer.
Clin Cancer Res
; 28(7): 1258-1267, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35046057
17.
Comparison of Radiation With or Without Concurrent Trastuzumab for HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy: A Phase III Clinical Trial.
J Clin Oncol
; 39(21): 2367-2374, 2021 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33739848
18.
Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer.
N Engl J Med
; 357(26): 2666-76, 2007 Dec 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-18160686
19.
Loss of STAT6 leads to anchorage-independent growth and trastuzumab resistance in HER2+ breast cancer cells.
PLoS One
; 15(6): e0234146, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32525891
20.
Paired tumor sequencing and germline testing in breast cancer management: An experience of a single academic center.
Cancer Rep (Hoboken)
; 3(6): e1287, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32881420